NICE - Articles and news items


Long term benefits of breast cancer drug pertuzumab too uncertain says NICE

Industry news / 20 May 2016 / Katie Sadler

NICE has announced it will not be recommending pertuzumab to treat HER2-positive breast cancer because it is uncertain of the long term benefits for patients.

NICE says ‘no’ to cystic fibrosis drug Orkambi in draft guidance

Industry news / 23 March 2016 / Victoria White

The independent appraisal committee concluded that the cost of Orkambi was considerably higher than the current standard of care and is not cost effective…

Transforming health technology assessment: the NICE perspective

Issue 3 2015, Manufacturing & Packaging / 3 July 2015 / Sir Andrew Dillon, Chief Executive, National Institute for Health and Care Excellence

Without constantly examining the systems that underpin what we as an organisation do, opportunities will be missed and performance will stagnate…


NICE publishes bladder cancer guideline, recommending photodynamic diagnosis to improve detection

Industry news / 2 March 2015 / Photocure ASA

Photocure ASA, a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, is pleased to announce that the National Institute for Health and Care Excellence (NICE) in the UK has published its first guidelines on bladder cancer, recommending photodynamic diagnosis for improved detection of bladder cancer…

Roche logo

NICE reverses decision on access to new blood cancer drug

Industry news / 2 December 2014 / Roche

Victory for patients as NICE accepts Gazyvaro™ (obinutuzumab) for treatment of most common adult leukaemia[1]…

Boehringer Ingelheim logo
Professor Gregory Lip, Consultant Cardiologist & Professor of Cardiovascular Medicine, University of Birmingham Centre for Cardiovascular Sciences, Birmingham, United Kingdom

Pradaxa® (dabigatran etexilate) receives final NICE recommendation for stroke prevention in atrial fibrillation in the UK

Industry news, News / 19 March 2012 / NICE

Pradaxa® must now be made available for use by the UK National Health Service (NHS)…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...